Dave B, Tailor J
BMC Cancer. 2024; 24(1):1465.
PMID: 39609728
PMC: 11603633.
DOI: 10.1186/s12885-024-13187-5.
Steel C, James E, Matthews J, Turner S
Methods Mol Biol. 2024; 2865:429-448.
PMID: 39424736
DOI: 10.1007/978-1-0716-4188-0_19.
Somatilaka B, Madana L, Sadek A, Chen Z, Chandrasekaran S, McKay R
J Clin Invest. 2024; 134(10).
PMID: 38502231
PMC: 11093615.
DOI: 10.1172/JCI176748.
Mukherjee N, Katsnelson E, Brunetti T, Michel K, Couts K, Lambert K
Cell Death Dis. 2024; 15(3):198.
PMID: 38459020
PMC: 10923779.
DOI: 10.1038/s41419-024-06524-w.
Anand S, Shen A, Cheng C, Chen J, Powers J, Rayman P
Photodiagnosis Photodyn Ther. 2024; 45:103983.
PMID: 38281610
PMC: 11197882.
DOI: 10.1016/j.pdpdt.2024.103983.
Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance.
Tajima Y, Shibasaki F, Masai H
Cancer Gene Ther. 2023; 31(1):158-173.
PMID: 37990063
DOI: 10.1038/s41417-023-00693-0.
Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response.
Udumula M, Singh H, Rashid F, Poisson L, Tiwari N, Dimitrova I
iScience. 2023; 26(10):107839.
PMID: 37822507
PMC: 10562806.
DOI: 10.1016/j.isci.2023.107839.
Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma.
Boboila S, Okochi S, Banerjee D, Barton S, Street C, Zenilman A
Heliyon. 2023; 9(6):e17399.
PMID: 37408891
PMC: 10319189.
DOI: 10.1016/j.heliyon.2023.e17399.
Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review).
Affolter A, Kern J, Bieback K, Scherl C, Rotter N, Lammert A
Int J Oncol. 2022; 61(1).
PMID: 35642667
PMC: 9183766.
DOI: 10.3892/ijo.2022.5378.
A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Papillomavirus.
King R, Bilger A, Rademacher J, Ward-Shaw E, Hu R, Lambert P
Viruses. 2022; 14(5).
PMID: 35632742
PMC: 9147793.
DOI: 10.3390/v14051000.
FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cells.
Chung Y, Tsai W, Khan P, Ma J, Berek J, Larrick J
Am J Cancer Res. 2022; 12(3):1241-1263.
PMID: 35411241
PMC: 8984903.
Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands.
Janjic B, Kulkarni A, Ferris R, Vujanovic L, Vujanovic N
Front Immunol. 2022; 13:837842.
PMID: 35392082
PMC: 8983021.
DOI: 10.3389/fimmu.2022.837842.
The mouse resource at National Resource Center for Mutant Mice.
Ju C, Liang J, Zhang M, Zhao J, Li L, Chen S
Mamm Genome. 2022; 33(1):143-156.
PMID: 35138443
DOI: 10.1007/s00335-021-09940-x.
Sterilized human skin graft with a dose of 25 kGy provides a privileged immune and collagen microenvironment in the adhesion of Nude mice wounds.
de Miranda J, Bringel F, Velosa A, Protocevich V, Fernezlian S, Silva P
PLoS One. 2022; 17(1):e0262532.
PMID: 35085314
PMC: 8794154.
DOI: 10.1371/journal.pone.0262532.
A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy.
Kim H, Seo M, Park T, Lee D
J Nanobiotechnology. 2022; 20(1):14.
PMID: 34983539
PMC: 8725459.
DOI: 10.1186/s12951-021-01220-9.
Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.
Xu P, Luan Y, Yu S, Xu J, Coulter D, Kim S
J Endocrinol. 2021; 252(1):15-30.
PMID: 34647523
PMC: 8630981.
DOI: 10.1530/JOE-21-0209.
MicroRNA-detargeting proves more effective than gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model.
Suryawanshi Y, Nace R, Russell S, Schulze A
Mol Ther Oncolytics. 2021; 23:1-13.
PMID: 34589580
PMC: 8455367.
DOI: 10.1016/j.omto.2021.08.011.
Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis.
Li X, Xu H, Huang J, Luo D, Lv S, Lu X
Front Pharmacol. 2021; 12:716081.
PMID: 34512345
PMC: 8428974.
DOI: 10.3389/fphar.2021.716081.
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.
Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga L
Cancer Immunol Res. 2021; 9(11):1298-1315.
PMID: 34462284
PMC: 9414288.
DOI: 10.1158/2326-6066.CIR-21-0543.
Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice.
Buranaphatthana W, Yavirach A, Leaf E, Scatena M, Zhang H, An J
Bone. 2021; 153:116144.
PMID: 34375732
PMC: 8555912.
DOI: 10.1016/j.bone.2021.116144.